Evidence map›Paper›PMID 29140481›Full record

ArticleBrain : a journal of neurology2017

Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.

Laurie A Robak, Iris E Jansen, Jeroen van Rooij, André G Uitterlinden, Robert Kraaij, Joseph Jankovic, International Parkinson’s Disease Genomics Consortium (IPDGC), Peter Heutink, Joshua M Shulman

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 267 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
267citing papers in PubMed, 4 pooled it
25.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

267 citing papers in PubMed, 4 syntheses or guidelines pooled it, 445 citations in OpenAlex.

  1. Pooled it
  2. Association of Rare Variants in ARSA with Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2023
    Pooled it
  3. Pooled it
  4. Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk.Movement disorders : official journal of the Movement Disorder Society · 2022
    Pooled it
  5. Article
  6. Review
  7. Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Metabolic profiles associated with fat loss in Parkinson's disease.Journal of neurology, neurosurgery, and psychiatry · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

207 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Laurie A RobakDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston TX USA.
Iris E JansenGerman Center for Neurodegenerative Diseases (DZNE) and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen 72076, Germany.
Jeroen van RooijDepartment of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.
André G UitterlindenDepartment of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.
Robert KraaijDepartment of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.
Joseph JankovicDepartment of Neurology, Baylor College of Medicine, Houston, TX, USA.
International Parkinson’s Disease Genomics Consortium (IPDGC)
Peter HeutinkGerman Center for Neurodegenerative Diseases (DZNE) and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen 72076, Germany.
Joshua M ShulmanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston TX USA.
Baylor College of Medicine · USErasmus MC · NLGerman Center for Neurodegenerative Diseases · DE

Funding

VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ROBAKIS, NIKOLAOS K · 1985 to 2019
$37.9M
Leucine rich repeat kinase 2 and dominantly inherited Parkinson diseaseZIAAG000948 · NIA · NATIONAL INSTITUTE ON AGING · PI COOKSON, MARK · 2009 to 2025
$18.3M
NRI Build-out: Advancing Translational Brain ResearchC06RR029965 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI ZOGHBI, HUDA Y · 2010 to 2010
$14.9M
PARKINSON DISEASE COLLABORATIVE STUDY OF GENETIC LINKAGER01NS037167 · NINDS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI FOROUD, TATIANA M. · 1998 to 2010
$11.7M
MEDICAL GENETICS RESEARCH FELLOWSHIP PROGRAMT32GM007526 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Brendan Lee · 1985 to 2026
$11.4M
Characterization of Normal Genomic VariabilityZIAAG000932 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2024
$11.3M
Vitamin D Concentration, Genetic Modifiers, and Parkinson DiseaseP50NS071674 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI VANCE, JEFFERY MARVIN · 2010 to 2015
$10.2M
INVESTIGATIONS OF DEMENTIA IN PARKINSON DISEASER01NS075321 · NINDS · WASHINGTON UNIVERSITY · PI CAMPBELL, MEGHAN C, PERLMUTTER, JOEL SYNES · 2011 to 2021
$8.2M
Tau-Spliceosome Interactions in Alzheimer's DiseaseR01AG053960 · NIA · BAYLOR COLLEGE OF MEDICINE · PI SEYFRIED, NICHOLAS THOMAS, SHULMAN, JOSHUA M · 2016 to 2020
$3.2M
Genome wide SNP analysis in Parkinson's diseaseZ01AG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW B · 2006 to 2008
$2.6M
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's DiseaseR01AG050631 · NIA · BAYLOR COLLEGE OF MEDICINE · PI SHULMAN, JOSHUA M · 2016 to 2020
$2.5M
Prospective studies on Parkinson's diseaseZ01ES101986 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CHEN, HONGLEI · 2006 to 2008
$1.2M
Intramural NIH HHS Z01 AG000949Intramural NIH HHS Z01 ES101986Medical Research Council G0700943Medical Research Council G1100643NCI NIH HHS R01 CA141668NCRR NIH HHS C06 RR029965NIA NIH HHS P50 AG005138NIA NIH HHS R01 AG050631NIA NIH HHS R01 AG053960NIGMS NIH HHS T32 GM007526NINDS NIH HHS P50 NS071674NINDS NIH HHS R01 NS037167NINDS NIH HHS R01 NS075321NINDS NIH HHS R21 NS089854Parkinson's UK H-1703Parkinson's UK J-0804Parkinson's UK J-0901Parkinson's UK K-1501Wellcome Trust
6 · The paper itself

Abstract

Mutations in the glucocerebrosidase gene (GBA), which cause Gaucher disease, are also potent risk factors for Parkinson's disease. We examined whether a genetic burden of variants in other lysosomal storage disorder genes is more broadly associated with Parkinson's disease susceptibility. The sequence kernel association test was used to interrogate variant burden among 54 lysosomal storage disorder genes, leveraging whole exome sequencing data from 1156 Parkinson's disease cases and 1679 control subjects. We discovered a significant burden of rare, likely damaging lysosomal storage disorder gene variants in association with Parkinson's disease risk. The association signal was robust to the exclusion of GBA, and consistent results were obtained in two independent replication cohorts, including 436 cases and 169 controls with whole exome sequencing and an additional 6713 cases and 5964 controls with exome-wide genotyping. In secondary analyses designed to highlight the specific genes driving the aggregate signal, we confirmed associations at the GBA and SMPD1 loci and newly implicate CTSD, SLC17A5, and ASAH1 as candidate Parkinson's disease susceptibility genes. In our discovery cohort, the majority of Parkinson's disease cases (56%) have at least one putative damaging variant in a lysosomal storage disorder gene, and 21% carry multiple alleles. Our results highlight several promising new susceptibility loci and reinforce the importance of lysosomal mechanisms in Parkinson's disease pathogenesis. We suggest that multiple genetic hits may act in combination to degrade lysosomal function, enhancing Parkinson's disease susceptibility.

Indexed as

Acid CeramidaseAdultAgedAged, 80 and overCase-Control StudiesCathepsin DCohort StudiesExomeFemaleGenetic Predisposition to DiseaseGenotypeGlucosylceramidaseHumansLysosomal Storage DiseasesMaleMiddle AgedAcid CeramidaseASAH1 protein, humanCathepsin DCTSD protein, humanGlucosylceramidaseOrganic Anion Transporterssialic acid transport proteinsSMPD1 protein, humanSphingomyelin PhosphodiesteraseSymportersgeneticslysosomal storage disordersParkinson’s diseasewhole exome sequencing

Identifiers

PMID29140481
PMCPMC5841393
OpenAlexW2782297377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.